News on Medial

Shapewear brand Underneat raises $6 Mn in pre-Series A led by Fireside Ventures

EntrackrEntrackr · 1d ago
Shapewear brand Underneat raises $6 Mn in pre-Series A led by Fireside Ventures
Medial

Shapewear brand Underneat has raised $6 million in a pre-Series A funding round led by Fireside Ventures, with participation from its existing investor Ghazal Alagh, co-founder of Honasa Consumer. The Gurugram-based startup had previously raised $2.51 million in a seed funding round from Fireside Ventures and others. The fresh capital will be deployed toward scaling operations and strengthening distribution channels across Indian cities, Underneat said in a press release. Co-founded in April 2025 by Kusha Kapila and Vimarsh Razdan, Underneat is a mass-premium innerwear brand offering high-quality, affordable solutions designed for the Indian woman’s body. With a product range spanning shapewear, innerwear, and accessories, the brand aims to combine style, comfort, and accessibility to redefine confidence wear in India. According to market research, India’s women’s innerwear market, currently valued at $5.06 billion, is projected to reach $9.57–12.0 billion by 2030–2033, growing at a CAGR of 8.4%–11.2%, driven by rising disposable incomes, increasing urbanisation, and e-commerce adoption. Since launch, Underneat says it has captured a meaningful share of India’s nascent shapewear category by offering quality products at accessible price points. The brand’s growth has been driven by strong product-market fit and direct consumer engagement across digital channels. It also claims to have crossed Rs 150 crore in ARR while remaining EBITDA positive.

Related News

Inito raises $29 Mn in Series B round led by Bertelsmann India

EntrackrEntrackr · 6d ago
Inito raises $29 Mn in Series B round led by Bertelsmann India
Medial

Inito raises $29 Mn in Series B round led by Bertelsmann India At-home diagnostics startup Inito has raised $29 million in a Series B round led by Bertelsmann India Investments, with participation from existing investor Fireside Ventures. The company’s total equity funding now stands at $45 million. It previously raised $6 million in a Series A round led by Fireside Ventures in November 2023. The new capital will support Inito’s move beyond fertility testing into broader hormone and health diagnostics built on AI-enabled antibody engineering. Inito entered the market in 2021 with an at-home fertility device that measures four hormone markers and interprets results using proprietary models. According to the company, the product has processed more than 30 million data points globally. After reaching scale in fertility monitoring, the company is developing tests for additional biomarkers across women’s and general health. Co-founders Aayush Rai and Varun AV said the next phase of the business focuses on using computational protein design to build synthetic antibodies. This approach replaces conventional antibody development, which relies on animal-derived material and manual screening. Inito aims to create a stable, consistent foundation for at-home diagnostic tests that historically required clinical infrastructure. The brand is building products for testosterone, thyroid, vitamins and other analytes, targeting a wider health-monitoring use case. Inito has teams across Bengaluru, Dubai and London and holds more than 20 patents linked to its testing platform.

Download the medial app to read full posts, comements and news.